Strategies for the Treatment of Antipsychotic-Induced Sexual Dysfunction and/or Hyperprolactinemia Among Patients of the Schizophrenia Spectrum: A Review

@article{Nunes2012StrategiesFT,
  title={Strategies for the Treatment of Antipsychotic-Induced Sexual Dysfunction and/or Hyperprolactinemia Among Patients of the Schizophrenia Spectrum: A Review},
  author={Luciana Vargas Alves Nunes and Hugo Cogo Moreira and Denise Razzouk and Sandra Odebrecht Vargas Nunes and Jair de Jesus Mari},
  journal={Journal of Sex \& Marital Therapy},
  year={2012},
  volume={38},
  pages={281 - 301}
}
There is limited evidence for the management of sexual dysfunction and/or hyperprolactinemia resulting from use of antipsychotics in patients with schizophrenia and spectrum. The aim of this study was to review and describe the strategies for the treatment of antipsychotic-induced sexual dysfunctions and/or hyperprolactinemia. The research was carried out through Medline/PubMed, Cochrane, Lilacs, Embase, and PsycINFO, and it included open labels or randomized clinical trials. The authors found… 
View on Taylor & Francis
ncbi.nlm.nih.gov
45 Citations
Highly Influential Citations
3
Background Citations
15
Methods Citations
1

45 Citations

Citation Type

Citation Type

Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review
Management of Antipsychotic-Related Sexual Dysfunction: Systematic Review.
Efficacy of tadalafil on erectile dysfunction in male patients using antipsychotics: a double-blind, placebo-controlled, crossover pilot study.
TLDR
The study described in this article is the first randomized, controlled trial to investigate the influence of the PDE-5 inhibitor tadalafil on erectile dysfunction in patients diagnosed with schizophrenia or a schizophrenia spectrum disorder treated with antipsychotics.
Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials
TLDR
Adjunctive metformin appears to be effective and safe for reducing antipsychotic-induced hyperprolactinemia and prolactin-related symptoms in schizophrenia patients and higher quality randomized controlled trials with a large sample size are warranted to confirm these findings.
Adjunctive treatment with lodenafil carbonate for erectile dysfunction in outpatients with schizophrenia and spectrum: a randomized, double-blind, crossover, placebo-controlled trial.
TLDR
The results indicate that both lodenafil and placebo were effective in the treatment of erectile dysfunction for schizophrenia and this study showed the importance of discussing sexuality and trying to treat these patients.
Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
TLDR
The rationale and protocol for an ongoing clinical trial to treat symptomatic hyperprolactinemia in premenopausal women with schizophrenia is presented.
Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics.
TLDR
The reviewed literature shows no consistent evidence that any one antipsychotic drug has a significantly superior side effect profile over another and current information on this topic is often based on methodologically weak research.
Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics
TLDR
Add-on mirtazapine appears to relieve orgasmic dysfunction in FGA-treated patients with schizophrenia.
ANTIPSYCHOTICS AND SEXUAL DYSFUNCTION: EPIDEMIOLOGY, MECHANISMS AND MANAGEMENT
TLDR
Clinicians should purposely investigate this side effect both before and after the prescription of a given antipsychotics and should be aware of strategies to manage antipsychotic-related SD.
Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
TLDR
Some management strategies for TESD from a clinical perspective are detailed, ranging from prevention (carefully choosing an antipsychotic with a low rate of TESd) to possible pharmacological interventions aimed at improving patients’ tolerability when TESS is present.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 73 REFERENCES
A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia.
INTRODUCTION Sexual dysfunction frequently occurs in patients with schizophrenia under antipsychotic therapy, and the presence of sexual side effects may affect compliance. The aim of this study was…
An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction
Frequency of Sexual Dysfunction and Other Reproductive Side-effects in Patients with Schizophrenia Treated with Risperidone, Olanzapine, Quetiapine, or Haloperidol: The Results of the EIRE Study
TLDR
The results suggest that none of the atypical antipsychotics that were studied significantly improved sexual dysfunction and other reproductive side-effects of the conventional antipsychotic, haloperidol, in stabilized patients during long-term treatment.
Change in sexual dysfunction with aripiprazole: a switching or add-on study
TLDR
It is concluded that switching to aripiprazole or the addition of aripIPrazole to another antipsychotic regime is associated with a reduction in sexual dysfunction.
A Randomized, Crossover Comparison of Herbal Medicine and Bromocriptine Against Risperidone-Induced Hyperprolactinemia in Patients With Schizophrenia
TLDR
The results suggest that the herbal therapy can yield additional benefits while having comparable efficacy in treating antipsychotic-induced hyperprolactinemia in individuals with schizophrenia.
Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine
Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial.
TLDR
Sildenafil citrate is safe and effective in the treatment of antipsychotic-induced erectile dysfunction and well tolerated and remained significant even after adjustment for period and week effects and treatment-period interaction with Poisson regression analysis.
Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study.
TLDR
Results suggest that low-dose cabergoline treatment of risperidone-induced hyperprolactinemia may be safe and clinically effective in a relevant number of patients.
Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: A pilot study
An open-label trial of sildenafil addition in risperidone-treated male schizophrenia patients with erectile dysfunction.
TLDR
Sildenafil is a useful agent for the treatment of erectile dysfunction in risperidone-treated male schizophrenia patients and statistically significant improvements in all sexual function domains are observed.
...
1
2
3
4
5
...